Results of NRG-RTOG 0436 highlight need for biomarkers in treatment of oesophageal cancer

NRG-RTOG 0436 has determined that adding an epidermal growth factor receptor (EGFR) inhibitor to a chemo-radiation regimen does not improve overall survival for patients with locally advanced oesophageal cancer treated in a non-operative manner.
EurekAlert